<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22180713</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>02</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2219-2840</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>42</Issue>
<PubDate>
<Year>2011</Year>
<Month>Nov</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>World journal of gastroenterology</Title>
<ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study.</ArticleTitle>
<Pagination>
<MedlinePgn>4704-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v17.i42.4704</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To describe the socio-demographic features, etiology, and risk factors for Budd-Chiari syndrome (BCS) in Egyptian patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Ninety-four Egyptian patients with confirmed primary Budd-Chiari syndrome were presented to the Budd-Chiari Study Group (BCSG) and admitted to the Tropical Medicine Department of Ain Shams University Hospital (Cairo, Egypt). Complete clinical evaluation and laboratory investigations, including a thrombophilia workup and full radiological assessment, were performed to determine underlying disease etiologies.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">BCS was chronic in 79.8% of patients, acute or subacute in 19.1%, and fulminant in 1.1%. Factor V Leiden mutation (FVLM) was the most common etiological cause of disease (53.1%), followed by mutation of the gene encoding methylene tetrahydrofolate reductase (MTHFR) (51.6%). Current or recent hormonal treatment was documented in 15.5% of females, and BCS associated with pregnancy was present in 17.2% of females. Etiology could not be determined in 8.5% of patients. Males had significantly higher rates of MTHFR gene mutation and Behçet's disease, and females had significantly higher rates of secondary antiphospholipid antibody syndrome. A highly significant positive relationship was evident between the presence of Behçet's disease and inferior vena caval occlusion, either alone or combined with occlusion of the hepatic veins (P &lt; 0.0001).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">FVLM is the most common disease etiology and MTHFR the second most common in Egyptian BCS patients. BCS etiology tends to vary with geographic region.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sakr</LastName>
<ForeName>Mohammad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Tropical Medicine, Faculty of Medicine, Ain Shams University, Abbassia, Cairo 11341, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barakat</LastName>
<ForeName>Eman</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abdelhakam</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dabbous</LastName>
<ForeName>Hany</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yousuf</LastName>
<ForeName>Said</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shaker</LastName>
<ForeName>Mohamed</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Eldorry</LastName>
<ForeName>Ahmed</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World J Gastroenterol</MedlineTA>
<NlmUniqueID>100883448</NlmUniqueID>
<ISSNLinking>1007-9327</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C095381">factor V Leiden</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9001-24-5</RegistryNumber>
<NameOfSubstance UI="D005165">Factor V</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.5.1.20</RegistryNumber>
<NameOfSubstance UI="D042965">Methylenetetrahydrofolate Reductase (NADPH2)</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006502">Budd-Chiari Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D004534">Egypt</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005165">Factor V</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042965">Methylenetetrahydrofolate Reductase (NADPH2)</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011248">Pregnancy Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Budd-Chiari syndrome</Keyword>
<Keyword MajorTopicYN="N">Epidemiological aspects</Keyword>
<Keyword MajorTopicYN="N">Etiology</Keyword>
<Keyword MajorTopicYN="N">Factor V Leiden mutation</Keyword>
<Keyword MajorTopicYN="N">Methylene tetrahydrofolate reductase gene mutation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2011</Year>
<Month>07</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>08</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22180713</ArticleId>
<ArticleId IdType="doi">10.3748/wjg.v17.i42.4704</ArticleId>
<ArticleId IdType="pmc">PMC3233677</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Hepatology. 2000 Mar;31(3):587-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10706547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 2009 Jan;50(1):195-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19012988</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Haematol. 2001 Jun;113(3):630-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11380448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2001 Oct;34(4 Pt 1):666-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11584361</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Liver Dis. 2002 Feb;22(1):5-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11928075</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Liver Dis. 2002 Feb;22(1):15-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11928076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hematol. 2002 Sep;71(1):11-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12221667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 2003 Mar;38(3):364-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12586305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2003 Oct;38(4):793-803</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14512865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2004 Feb;39(2):500-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14768004</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Immunol Immunopathol. 1987 Sep;44(3):297-307</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3497746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1990 May 5;335(8697):1078-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1970380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Probl Surg. 1996 Feb;33(2):83-211</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8595784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1996 Aug 31;348(9027):573-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8774569</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 1997 Feb;26(2):293-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9059949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Gastroenterol. 1997 May;92(5):858-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9149201</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2005 Mar;41(3):603-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15726653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Haematol. 2005 May;129(4):553-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15877740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2006 Jun;130(7):2031-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16762626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2006 Dec;44(6):1528-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17133457</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2007 Jan;5(1):55-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17059429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Haematol Suppl. 2007 Oct;(68):9-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17727558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2008 May 15;111(10):4922-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18250227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2008 May 14;14(18):2858-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18473410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood Coagul Fibrinolysis. 2008 Jul;19(5):459-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18600100</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 2008 Oct;57(10):1469-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18583397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 2001 Feb;48(2):264-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11156651</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>